Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Low-dose Paclitaxel Plus Cisplatin for Metastatic Breast Cancer
NCT00154882Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in breast cancer, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00154882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154882.